AXA (XSWX:CS) YoY EBITDA Growth: 14.90% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:CS AXA SA XSWX:CS
56 GF Score
Price CHF40.69
GF Value CHF39.77
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is AXA YoY EBITDA Growth?

AXA XSWX:CS 56 YoY EBITDA Growth is 14.90% as of Jun. 2026. GuruFocus rates XSWX:CS with a GF Score™ of 56/100 and a GF Value™ of CHF39.77 (Fairly Valued). The stock has 5 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. AXA's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was 14.90%.

AXA's EBITDA per Share for the six months ended in Jun. 2026 was CHF2.75.

AXA YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for AXA's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AXA YoY EBITDA Growth Chart

AXA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 61.79 -28.46 21.71 11.73 2.02

AXA Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.76 34.12 -0.62 5.87 14.90
XSWX:CS
56GF Score
AXA SA XSWX:CS
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AXA YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

AXA's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(4.345-4.259)/ | 4.259 |
=2.02 %

AXA's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(2.746-2.39)/ | 2.39 |
=14.90 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 14.90% mean?
AXA (XSWX:CS) has a YoY EBITDA Growth of 14.90% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for AXA and its competitors.
Is AXA's YoY EBITDA Growth too high?
AXA's current YoY EBITDA Growth is 14.90%. Overall, AXA has a GF Score™ of 56/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does AXA's YoY EBITDA Growth compare to BRK.A and AIG?
AXA's YoY EBITDA Growth of 14.90% can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for an Insurance company?
A good YoY EBITDA Growth depends on the Insurance industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for AXA and its competitors. AXA's current YoY EBITDA Growth is 14.90%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AXA stock overvalued right now?
Based on GuruFocus' analysis, AXA (XSWX:CS) is currently considered Fairly Valued. The stock's GF Value™ is CHF39.77, compared to a current price of CHF40.69 — trading 2.3% above its estimated fair value. The current YoY EBITDA Growth is 14.90%. AXA's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For AXA (XSWX:CS), the current YoY EBITDA Growth is 14.90% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AXA (XSWX:CS) Overvalued in 2026?

Based on GuruFocus' analysis, AXA stock appears to be overvalued. The current stock price of CHF40.69 is trading 2.3% above its estimated GF Value™ of CHF39.77. GuruFocus considers AXA to be Fairly Valued.

Key valuation signals for XSWX:CS:

  • YoY EBITDA Growth: 14.90%
  • GF Value™: CHF39.77 vs. price of CHF40.69 (2.3% above fair value)
  • GF Score™: 56/100 with 5 warning signs

No single metric tells the full story. See the XSWX:CS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AXA Business Description

Address 25, Avenue Matignon, Paris, FRA, 75008
AXA's origins date back to Ancienne Mutuelle, one of the few insurers that remained after the creation of the French social security system. With the threat of nationalization, a merger took place between Drouot and AXA, which was then still known as Mutuelles Unies in 1982, and later Présence. Ten years later, AXA acquired North American life insurer Equitable Holdings. This was a time of expansion as AXA also bought the French insurer UAP. As markets crashed at the turn of the millennium, AXA decided to refocus its business and exited its stake in US investment bank Donaldson, Lufkin & Jenrette. A few years later, the business expanded again with the acquisition of Swiss insurer Winterthur. AXA has reshaped its portfolio to technical risks.
56GF Score

Get the complete analysis for XSWX:CS

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF40.69
Price
CHF39.77
GF Value